Cbiz Investment Advisory Services, LLC Gilead Sciences, Inc. Transaction History
Cbiz Investment Advisory Services, LLC
- $2 Billion
- Q4 2024
A detailed history of Cbiz Investment Advisory Services, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cbiz Investment Advisory Services, LLC holds 43 shares of GILD stock, worth $4,475. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43
Previous 20
115.0%
Holding current value
$4,475
Previous $1,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding GILD
# of Institutions
2,072Shares Held
1.02BCall Options Held
9.63MPut Options Held
10.2M-
Black Rock Inc. New York, NY121MShares$12.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.46 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.28 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.03 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $130B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...